Weight regain after stopping GLP-1
Clinical evidence shows that stopping GLP-1 treatment is typically followed by weight regain. Most of the regain happens within the first year. Understanding why this happens and spotting early drift signals can help.
Why this matters
Weight regain after stopping GLP-1 treatment is one of the most important topics for anyone using these medicines — and for the funders and employers paying for them. Understanding the evidence helps set realistic expectations and highlights why maintenance support matters.
What the evidence shows
Several large studies have examined what happens after GLP-1 discontinuation:
- Extension studies show that participants who stopped semaglutide regained approximately two-thirds of the weight they had lost within one year
- Cardiometabolic improvements (blood pressure, cholesterol, blood sugar) also tended to reverse after stopping
- Real-world data suggests similar patterns, with most regain occurring within 6-12 months
Why regain happens
Regain after stopping GLP-1 treatment is not a personal failure — it reflects the underlying biology. GLP-1 medicines work by suppressing appetite and regulating metabolic processes. When the medicine is removed, these biological mechanisms return to their previous state:
- Appetite signals increase again
- Metabolic adaptations favour weight regain
- The body's “set point” mechanisms work to restore previous weight
How Healthcount helps
Whether someone is continuing treatment or transitioning off it, Healthcount helps by detecting early drift signals — the changes that happen before the scales move. An occasional weight datapoint, optional activity and sleep trends, and lightweight check-ins provide enough signal to spot patterns early.
Healthcount does not prescribe, diagnose, or advise dose changes. It supports maintenance and signposts to clinical support when needed.